Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 91.33% is in line with its 5-year average of 90.31%, near the high end of its 5-year range (82.92%–92.96%).
0.24% below its 12-month average of 91.55%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 92.96%.
GROSS MARGIN
91.33%
GROSS MARGIN AVG TTM
91.55%
GROSS MARGIN AVG 3Y
90.46%
GROSS MARGIN AVG 5Y
90.31%
GROSS MARGIN AVG 10Y
89.62%
GROSS MARGIN AVG 15Y
85.62%
GROSS MARGIN AVG 20Y
74.70%
CURRENT VS TTM AVG
-0.24%
CURRENT VS 3Y AVG
+0.96%
CURRENT VS 5Y AVG
+1.13%
CURRENT VS 10Y AVG
+1.91%
CURRENT VS 15Y AVG
+6.67%
CURRENT VS 20Y AVG
+22.27%
SECTOR MEDIAN · HEALTHCARE
41.38%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
+120.71%
vs the sector median at left
Sanara MedTech Inc.
Market Cap
$321.62M
Gross Margin
91.33%
TTM Avg
91.55%
3Y Avg
90.46%
5Y Avg
90.31%
Market Cap
$323.14M
Gross Margin
62.61%
TTM Avg
61.15%
3Y Avg
61.24%
5Y Avg
64.05%
Market Cap
$320.22M
Gross Margin
81.56%
TTM Avg
83.99%
3Y Avg
83.73%
5Y Avg
82.68%
Market Cap
$312.35M
Gross Margin
77.81%
TTM Avg
88.91%
3Y Avg
85.13%
5Y Avg
50.71%
Market Cap
$302.45M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
25.00%
5Y Avg
13.20%
Market Cap
$303.86M
Gross Margin
81.07%
TTM Avg
81.07%
3Y Avg
81.07%
5Y Avg
81.07%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Sanara MedTech Inc. (SMTI) | $321.62M | 91.33% | 91.55% | 90.46% | 90.31% |
| Cabaletta Bio, Inc. (CABA)vs › | $322.03M | 0.00% | 0.00% | 0.00% | 0.00% |
| ClearPoint Neuro, Inc. (CLPT)vs › | $323.14M | 62.61% | 61.15% | 61.24% | 64.05% |
| Agenus Inc. (AGEN)vs › | $320.23M | 29.63% | -10.58% | -43.61% | -33.41% |
| Avita Medical Inc. (RCEL)vs › | $320.22M | 81.56% | 83.99% | 83.73% | 82.68% |
| CapsoVision, Inc. (CV)vs › | $325.26M | 50.88% | 53.58% | 54.49% | 54.49% |
| C4 Therapeutics, Inc. (CCCC)vs › | $312.35M | 77.81% | 88.91% | 85.13% | 50.71% |
| Benitec Biopharma Inc. (BNTC)vs › | $302.45M | 0.00% | 0.00% | 25.00% | 13.20% |
| Mobia Medical, Inc. Common Stock (MOBI)vs › | $303.86M | 81.07% | 81.07% | 81.07% | 81.07% |
| Relmada Therapeutics, Inc. (RLMD)vs › | $348.23M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
91.3%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 92.96% |
| 2026-03-31 | 90.97% |
| 2025-12-31 | 90.77% |
| 2025-09-30 | 90.56% |
| 2025-06-30 | 92.50% |
| 2025-03-31 | 89.21% |
| 2024-12-31 | 91.45% |
| 2024-09-30 | 90.81% |
| 2024-06-30 | 90.04% |
| 2024-03-31 | 89.80% |
| 2023-12-31 | 89.89% |
| 2023-09-30 | 89.07% |
| 2023-06-30 | 86.11% |
| 2023-03-31 | 86.31% |
| 2022-12-31 | 84.53% |
| 2022-09-30 | 82.92% |
| 2022-06-30 | 90.09% |
| 2022-03-31 | 89.69% |
| 2021-12-31 | 88.87% |
| 2021-09-30 | 91.11% |
| 2021-06-30 | 91.45% |
| 2021-03-31 | 90.53% |
| 2020-12-31 | 89.77% |
| 2020-09-30 | 89.60% |
| 2020-06-30 | 88.25% |
| 2020-03-31 | 90.63% |
| 2019-12-31 | 89.64% |
| 2019-09-30 | 90.20% |
| 2019-06-30 | 88.90% |
| 2019-03-31 | 88.37% |
| 2018-12-31 | 52.42% |
| 2018-09-30 | 92.60% |
| 2018-06-30 | 93.02% |
| 2018-03-31 | 89.25% |
| 2017-12-31 | 85.98% |
| 2017-09-30 | 85.15% |
| 2017-06-30 | 88.69% |
| 2017-03-31 | 89.18% |
| 2016-12-31 | 81.03% |
| 2016-09-30 | 84.99% |
| 2016-06-30 | 83.29% |
| 2016-03-31 | 82.59% |
| 2015-12-31 | 61.49% |
| 2015-09-30 | 78.23% |
| 2015-06-30 | 72.44% |
| 2015-03-31 | 78.59% |
| 2014-12-31 | 82.08% |
| 2014-09-30 | 65.37% |
| 2014-06-30 | 50.50% |
| 2014-03-31 | 75.27% |
| 2013-12-31 | 76.41% |
| 2013-09-30 | 49.50% |
| 2013-06-30 | 44.74% |
| 2013-03-31 | 42.60% |
| 2012-12-31 | 36.92% |
| 2012-09-30 | 41.87% |
| 2012-06-30 | 28.24% |
| 2012-03-31 | -13.64% |
| 2011-12-31 | 72.94% |
| 2011-09-30 | -179.07% |
| 2011-06-30 | 62.82% |
| 2011-03-31 | 89.91% |
| 2010-12-31 | 68.79% |
| 2010-09-30 | -165.68% |
| 2010-06-30 | 75.28% |
| 2010-03-31 | 69.42% |
| 2009-12-31 | -916.42% |
| 2009-09-30 | 4.67% |
| 2009-06-30 | -82.13% |
| 2009-03-31 | -480.49% |
| 2008-12-31 | -99.12% |
| 2008-09-30 | 36.65% |
| 2008-06-30 | 5.11% |
| 2008-03-31 | -134.29% |
| 2007-12-31 | 79.01% |
| 2007-09-30 | 59.38% |
| 2007-06-30 | 63.20% |
| 2007-03-31 | 67.84% |
| 2006-12-31 | -56.34% |
| 2006-09-30 | 33.02% |
| 2006-06-30 | 12.70% |
| 2006-03-31 | 18.37% |
| 2005-12-31 | -195.32% |
| 2005-09-30 | 33.55% |
| 2005-06-30 | 12.33% |
| 2005-03-31 | 5.15% |
| 2004-12-31 | -314.48% |
| 2004-09-30 | 27.56% |
| 2004-06-30 | 100.00% |
| 2004-03-31 | 100.00% |
| 2002-03-31 | 0.00% |
| 2001-12-31 | 47.08% |
| 2001-09-30 | 32.42% |
| 2001-06-30 | 23.58% |
| 2001-03-31 | 56.91% |
| 2000-12-31 | 52.50% |
